GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Price-to-Funds-From-Operations

Australian Clinical Labs (ASX:ACL) Price-to-Funds-From-Operations : (As of Jun. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.